149 related articles for article (PubMed ID: 9252073)
1. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection.
Tsubota A; Kumada H; Chayama K; Arase Y; Saitoh S; Koida I; Suzuki Y; Kobayashi M; Murashima N; Ikeda K
J Hepatol; 1997 Jul; 27(1):49-55. PubMed ID: 9252073
[TBL] [Abstract][Full Text] [Related]
2. Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B.
Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Kumada H
Am J Gastroenterol; 1999 Nov; 94(11):3304-9. PubMed ID: 10566734
[TBL] [Abstract][Full Text] [Related]
3. Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.
de Alava E; Camps J; Pardo-Mindán J; García-Granero M; Muñoz M; Sola J; Civeira MP; Contreras F; Vázquez JJ; Castilla A
Liver; 1993 Apr; 13(2):73-9. PubMed ID: 8510490
[TBL] [Abstract][Full Text] [Related]
4. The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.
Cammà C; Giunta M; Linea C; Pagliaro L
J Hepatol; 1997 Jun; 26(6):1187-99. PubMed ID: 9210603
[TBL] [Abstract][Full Text] [Related]
5. A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C.
Ziol M; Nhieu JT; Roudot-Thoraval F; Métreau JM; Deugnier Y; Dhumeaux D; Zafrani ES
J Hepatol; 1996 Dec; 25(6):833-41. PubMed ID: 9007710
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation.
Manabe N; Chevallier M; Chossegros P; Causse X; Guerret S; Trépo C; Grimaud JA
Hepatology; 1993 Dec; 18(6):1344-9. PubMed ID: 8244259
[TBL] [Abstract][Full Text] [Related]
7. [A prospective study on histological and serological changes after interferon alpha-2b treatment in patients with chronic hepatitis B infection].
Lang Z; Zhao C; Xu D
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):145-7. PubMed ID: 11517899
[TBL] [Abstract][Full Text] [Related]
8. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
Everson GT; Jensen DM; Craig JR; van Leeuwen DJ; Bain VG; Ehrinpreis MN; Albert D; Joh T; Witt K
Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
[TBL] [Abstract][Full Text] [Related]
11. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
12. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.
Shiffman ML; Hofmann CM; Thompson EB; Ferreira-Gonzalez A; Contos MJ; Koshy A; Luketic VA; Sanyal AJ; Mills AS; Garrett CT
Hepatology; 1997 Sep; 26(3):780-5. PubMed ID: 9303513
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
[TBL] [Abstract][Full Text] [Related]
14. Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
van Zonneveld M; Zondervan PE; Cakaloglu Y; Simon C; Akarca US; So TM; Flink HJ; de Man RA; Schalm SW; Janssen HL;
Liver Int; 2006 May; 26(4):399-405. PubMed ID: 16629642
[TBL] [Abstract][Full Text] [Related]
15. Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained response.
Reichard O; Glaumann H; Weiland O
Scand J Infect Dis; 1994; 26(4):383-9. PubMed ID: 7984968
[TBL] [Abstract][Full Text] [Related]
16. Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.
Toccaceli F; Laghi V; Capurso L; Koch M; Sereno S; Scuderi M;
J Viral Hepat; 2003 Mar; 10(2):126-33. PubMed ID: 12614469
[TBL] [Abstract][Full Text] [Related]
17. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.
Tsubota A; Chayama K; Ikeda K; Yasuji A; Koida I; Saitoh S; Hashimoto M; Iwasaki S; Kobayashi M; Hiromitsu K
Hepatology; 1994 May; 19(5):1088-94. PubMed ID: 8175130
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.
Shindo M; Arai K; Okuno T
J Hepatol; 1997 Mar; 26(3):492-7. PubMed ID: 9075654
[TBL] [Abstract][Full Text] [Related]
20. Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon alpha therapy.
Bruno S; Manzin A; Roncalli M; Petroni ML; Rossi S; Pedicino M; Larghi A; Crosignani A; Podda M
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):31-7. PubMed ID: 9265576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
